An Exploratory Study to Determine the Potential Impact of Parental Attendance at WW on Weight and Behavioural Outcomes in Children: WWChild

NCT ID: NCT04242641

Last Updated: 2021-08-31

Basic Information

• Recruitment Status: TERMINATED
• Clinical Phase: NA
• Total Enrollment: 2 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-01-24
• Study Completion Date: 2020-04-01

Brief Summary

The purpose of the WWChild study is to determine the feasibility of assessing the potential impact of parents attendance at WW on their child's weight status and weight related behaviours. The feasibility study will randomly allocate 60 parent participants to either the WW programme (formally Weight Watchers) or to a control arm. Data will be collected from both parent and child at baseline and at three months to explore changes in weight status and weight related behaviours.

Detailed Description

Study objectives:

1. To determine if it is possible to recruit parents who have a BMI ≥25 with children whose BMI is over the 85th percentile and assess the recruitment rate.

2. To assess the acceptability and feasibility of collecting height and weight data from both the parent and child during two assessment visits (baseline and follow-up).

3. To explore trends and variance in outcomes between treatment allocation to support the utility of a future definitive trial and to develop a sample size calculation.

4. To assess the acceptability and sensitivity of secondary outcome measures to evaluate the potential impact of parental attendance at WW on weight related behaviours of the family and child (eg. eating habits and physical activity levels).

5. To test the assumptions in the logic model through which parental participation is assumed to impact on child outcomes (Programme Theory).

WWChild is a randomised feasibility study with an embedded process evaluation, aiming to recruit 60 participants. Participants will be recruited through advertising using relevant channels that will target parents of children of primary school age.

All eligible participants will be registered and allocated to either 3 month programme with WW or to a waiting list control arm. Participants initially randomised to the control arm will receive free access to 3 month programme with WW after follow up data has been collected. Children will not attend the WW sessions.

Screening of participants will take place at multiple time-points. The initial screen will be conducted online by people who are interested in the study (self-referred). Those potentially meeting eligibility criteria will be asked to contact researchers at the Clinical Trials Research Unit by telephone or email, who will provide more information about the study and re-assess eligibility. If potentially eligible and interested, they will be invited to a baseline assessment visit, where eligibility will be confirmed, consent will be obtained, participants will be registered and baseline data will be collected. Participants will also be randomised at the end of this visit.

Conditions

Obesity, Childhood

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

WW (formally Weight Watchers)

The intervention will consist of engaging with the WW programme for 12 weeks, including weekly attendance at a local WW workshop and access to digital tools. Only the parent will take part in the WW intervention. No modifications will be made to the current WW programme to support child weight loss.

Group Type: EXPERIMENTAL

WW

Intervention Type: BEHAVIORAL

WW is a structured lifestyle modification, weight-loss programme involving a programme for healthy eating, physical activity and positive mindset and support via attendance at local WW workshops and digital tools.

Control

Participants randomised to the control group will receive no intervention during the 3 month period. Following final data collection control participants will receive 3 month complimentary access to WW.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

WW

WW is a structured lifestyle modification, weight-loss programme involving a programme for healthy eating, physical activity and positive mindset and support via attendance at local WW workshops and digital tools.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

1. Male or female ages 18-75 years

2. Body Mass Index (BMI) of 25 to 45 (confirmed at baseline by researcher measurement)

3. Self report need to lose weight. Parent/primary care-giver to a child meeting child eligibility criteria

4. Willing to discontinue any current over-the-counter (OTC) supplements not recommended/prescribed by physician, with the exception of multivitamins or other vitamin supplement

5. Willing to follow recommendations required by study protocol (2 appointments), including attending programme workshops and using App if assigned to the WW arm

6. Use of a personal smartphone (iOS 9.0 or Android 4.1 or higher with at least 54MB of available storage for Android or 154 MB for iPhone to accommodate the size of the WW app)

7. Residing within 30 miles of a WW workshop

8. Ability to read, write and speak English at an adequate level to receive the intervention

1. Must be at or over the 85th percentile (confirmed at baseline by researcher measurement)

2. Must be aged between 5 and 11 years at baseline

3. Must live with enrolled parent for the majority of the time

Exclusion Criteria

1. Membership at WW within the past 12 months.

2. Given birth in the past six months, currently pregnant, or planning on becoming pregnant over the next 3 months.

3. Weight loss of ≥ 5 kg in the previous 6 months.

4. History of heart problems (e.g., angina, bypass surgery, myocardial infarction, etc.) within previous 6 months.

5. Untreated thyroid disease or any changes (type or dose) in thyroid medication in last 6 months.

6. Resting systolic blood pressure >160 mmHg or resting diastolic blood pressure >100 mmHg (asked as 'high blood pressure in on-line/telephone screen; confirmed at baseline visit)

7. Currently have type 1 or type II diabetes (pre-diabetes acceptable);

8. Currently have chronic/inflammatory gastrointestinal disorder (irritable bowel syndrome acceptable)

9. Reported health problems that make weight loss or unsupervised exercise unsafe or unreasonable (e.g., orthopedic limitations, heart problems)

10. Taking any prescription medication with known effects on appetite or weight (e.g., oral steroids, weight loss medications such as Qysmia, Contrave, with the exception of those on a stable dose of SSRIs for at least 6 months

11. Ever had surgical procedure for weight loss.

12. Major surgery within the previous 12 months.

13. Presence of implanted cardiac defibrillator or pacemaker.

14. History of cancer within past 5 years or current treatment for cancer (if skin cancer, past 6 months)

15. Currently have a medical diagnosis of Anorexia Nervosa or Bulimia Nervosa

16. Hospitalisation for psychiatric problems during the past 12 months

17. Planning to relocate in the next 12 months

18. Another member (excluding the enrolled child) of the household is participating in this research study

1. Currently enrolled in any weight loss related programmes

2. Diagnosed with Prader- Willi syndrome, Cushing Syndrome, Hypothyroidism or Hashimoto's Disease.

3. Weight loss of ≥ 5% in the previous 6 months.

4. Untreated thyroid disease or any changes (type or dose) in thyroid medication in last 6 months.

5. Currently have type 1 or type II diabetes (pre-diabetes acceptable);

6. Currently have chronic/inflammatory gastrointestinal disorder (irritable bowel syndrome acceptable)

7. Reported health problems that make weight loss or unsupervised exercise unsafe or unreasonable (e.g., orthopedic limitations, heart problems)

8. Taking any prescription medication with known effects on appetite or weight.

9. Major surgery within the previous 12 months.

10. Presence of implanted cardiac defibrillator or pacemaker.

11. History of cancer within past 5 years or current treatment for cancer

12. Hospitalisation for psychiatric problems during the past 12 months

13. Another child of the household is participating in this research study

-

• Minimum Eligible Age: 5 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

WW International Inc

INDUSTRY

Sponsor Role: collaborator

University of Leeds

OTHER

Sponsor Role: lead

Responsible Party

Maria Bryant

Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Maria Bryant, PhD

Role: PRINCIPAL_INVESTIGATOR

Clinical Trials Research Unit, University of Leeds

Locations

Clinical Trials Research Unit, University of Leeds

Leeds, West Yorkshire, United Kingdom

Countries

United Kingdom

Other Identifiers

MREC 19-0.23

Identifier Type: -

Identifier Source: org_study_id